Indications |
Oral Moderate to severe pain Adult: As conventional tablet: 50-100 mg every 4-6 hr. Max: 400 mg daily. As extended-release tablet: 50-100 mg once or twice daily. Max: 300 mg daily. Elderly: Lower initial dose. Max: 300 mg daily (>75 yr). Max Dosage: 400 mg daily.
Parenteral Moderate to severe pain Adult: IM/IV inj over 2-3 min/IV infusion: 50-100 mg given every 4-6 hr. Elderly: Lower initial dose. Max: 300 mg daily (>75 yr).
Parenteral Postoperative pain Adult: IM/IV inj over 2-3 min/IV infusion: Initially, 100 mg followed by 50 mg every 10-20 min if necessary up to 250 mg for the 1st hr. Maintenance: 50-100 mg every 4-6 hr. Max: 600 mg daily. Elderly: Lower initial dose. Max: 300 mg daily (>75 yr).
Rectal Moderate to severe pain Adult: 100 mg suppository up to 4 times daily. Elderly: Lower initial dose. Max: 300 mg daily (>75 yr).
Special Populations: A dosage interval of 12 hrs is recommended in severe hepatic impairment. Incompatibility: Incompatible with injections of diazepam, diclofenac sodium, indometacin, midazolam, piroxicam, phenylbutazone, aciclovir, clindamycin and lysine aspirin if mixed in the same syringe. |
||||||||||||||||||||||||
Contraindications |
Suicidal patients, acute alcoholism; head injuries; raised intracranial pressure; severe renal impairment; lactation. | ||||||||||||||||||||||||
Warnings / Precautions |
Hypothyroidism; adrenocortical insufficiency; renal or hepatic impairment; history of epilepsy or increased risk of seizures; inflammatory or obstructive bowel disease; myasthaenia gravis; respiratory depression; prostatic hyperplasia. Pregnancy. | ||||||||||||||||||||||||
Adverse Reactions |
Sweating, dizziness, nausea, vomiting, dry mouth, fatigue, asthenia, somnolence, confusion, constipation, flushing, headache, vertigo, tachycardia, palpitations, miosis, insomnia, orthostatic hypotension, seizures, CNS stimulation e.g. hallucinations. Potentially Fatal: Respiratory depression. |
||||||||||||||||||||||||
Overdose Reactions |
Symptoms: Miosis, vomiting, cold and clammy skin, respiratory depression, lethargy, flaccid skeletal muscle, coma, seizures, bradycardia, hypotension, cardiac arrest, cardiac collapse and death. Management: Treatment is supportive and ensure adequate ventilation. Although naloxone will reverse some, but not all, symptoms of tramadol overdosage, there is an increased risk of seizures which has to be taken into consideration. Haemodialysis is unlikely to be helpful. | ||||||||||||||||||||||||
Drug Interactions |
Possible increase in anticoagulation with warfarin. Increased risk of seizures with SSRI, TCA. Increased risk of serotonin syndrome with mirtazapine, venlafaxine, SSRI and MAOI; tramadol should not be given to patients receiving MAOIs or within 14 days of their discontinuation. Reduced analgesic efficacy of tramadol with carbamazepine, 5-HT3-receptor antagonist e.g. ondansetron. Increased respiratory and CNS depression with CNS depressants e.g. alcohol, opioids, anaesthetic agents, narcotics, phenothiazines, tranquilisers or sedative hypnotics. See Below for More tramadol Drug Interactions |
||||||||||||||||||||||||
Mechanism of Actions |
Tramadol inhibits reuptake of norepinephrine, serotonin and enhances serotonin release. It alters perception and response to pain by binding to mu-opiate receptors in the CNS. Onset: Oral (conventional tablet): 1 hr. Duration: Oral (conventional tablet): 3-6 hr. Absorption: Readily absorbed from the GI tract (oral). Distribution: Widely distributed. Crosses the placenta and enters breast milk. Metabolism: Extensive hepatic first-pass metabolism; converted to O-desmethyltramadol (active) by N- and O-demethylation via the cytochrome P450 isoenzymes CYP3A4 and CYP2D6 and glucuronidation or sulfation. Excretion: Via urine (as metabolites); 6 hr (elimination half-life). |
||||||||||||||||||||||||
Administration |
May be taken with or without food. |
||||||||||||||||||||||||
Storage Conditions |
Oral: Store at 20-25°C (68-77°F). Parenteral: Do not store above 30°C. | ||||||||||||||||||||||||
ATC Classification |
N02AX02 - tramadol ; Belongs to the class of other opioids. Used to relieve pain. | ||||||||||||||||||||||||
Storage |
Oral: Store at 20-25°C (68-77°F). Parenteral: Do not store above 30°C. | ||||||||||||||||||||||||
Available As |
|
Tramadol
2 Responses to Tramadol
Post Review about Tramadol Click here to cancel reply.
Tramadol Containing Brands
Tramadol is used in following diseases
Drug - Drug Interactions of Tramadol
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
Is tramdol safe in lactation?
The excretion of tramadol into milk is low and even lower amounts of the active metabolite, O-desmethyltramadol, are excreted. With usual maternal dosage, the amount excreted into breastmilk is much less than the dose given to newborn infants for analgesia. A study in breastfed newborn infants found no adverse effects attributable to tramadol. Tramadol is unlikely to adversely affect nursing infant and is acceptable to use during breastfeeding.